Literature DB >> 9041195

Isolation of murine and human homologues of the fission-yeast dis3+ gene encoding a mitotic-control protein and its overexpression in cancer cells with progressive phenotype.

J Lim1, T Kuroki, K Ozaki, H Kohsaki, T Yamori, T Tsuruo, S Nakamori, S Imaoka, M Endo, Y Nakamura.   

Abstract

To investigate genes involved in metastasis, we used a differential display method to compare the levels of gene expression in three cell lines derived from murine colon-adenocarcinoma 26 that show different metastatic potentials. The results, and subsequent Northern analyses, confirmed that one gene was expressed most strongly in NL17, the cell line with the highest experimentally metastatic potential to the lung; strongly in NL22, the line with moderately metastatic potential; and very weakly in NL4, which has no metastatic potential in recipient mice. Using this fragment as a probe, we isolated the murine cDNA as well as its human homologue and determined their DNA sequences. The cDNA sequences from both species contained open reading frames of 2874 nucleotides, encoding peptides of 958 amino acids with calculated molecular weights of approximately 109,000; the murine and human nucleotide sequences were 90% identical. The deduced amino acid sequences of these cDNAs revealed significant homology (45% identity) to the dis3+ gene product of Schizosaccharomyces pombe, a protein thought to be essential for mitotic control in the yeast. We therefore termed the murine and human genes hmc (homologue to the mitotic-control gene) and HMC, respectively. In 7 of 13 patients with colorectal cancers and liver metastases, expression of HMC was increased up to 38-fold in primary tumors and metastatic foci as compared to adjacent normal colorectal mucosa. An increase in expression of HMC, its novel product likely to belong to a structurally distinct family of mitotic-control proteins, may be associated with malignant phenotypes of some colorectal cancers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041195

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.

Authors:  Amy E Rose; Laura Poliseno; Jinhua Wang; Michael Clark; Alexander Pearlman; Guimin Wang; Eleazar C Vega Y Saenz de Miera; Ratna Medicherla; Paul J Christos; Richard Shapiro; Anna Pavlick; Farbod Darvishian; Jiri Zavadil; David Polsky; Eva Hernando; Harry Ostrer; Iman Osman
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

2.  Characterization of the Drosophila melanogaster Dis3 ribonuclease.

Authors:  Megan Mamolen; Erik D Andrulis
Journal:  Biochem Biophys Res Commun       Date:  2009-10-02       Impact factor: 3.575

3.  Ribonuclease activity of Dis3 is required for mitotic progression and provides a possible link between heterochromatin and kinetochore function.

Authors:  Hiroaki Murakami; Derek B Goto; Takashi Toda; Ee Sin Chen; Shiv I Grewal; Robert A Martienssen; Mitsuhiro Yanagida
Journal:  PLoS One       Date:  2007-03-21       Impact factor: 3.240

Review 4.  The 3' to 5' Exoribonuclease DIS3: From Structure and Mechanisms to Biological Functions and Role in Human Disease.

Authors:  Sophie R Robinson; Antony W Oliver; Timothy J Chevassut; Sarah F Newbury
Journal:  Biomolecules       Date:  2015-07-17

5.  Multiple myeloma-associated hDIS3 mutations cause perturbations in cellular RNA metabolism and suggest hDIS3 PIN domain as a potential drug target.

Authors:  Rafal Tomecki; Karolina Drazkowska; Iwo Kucinski; Krystian Stodus; Roman J Szczesny; Jakub Gruchota; Ewelina P Owczarek; Katarzyna Kalisiak; Andrzej Dziembowski
Journal:  Nucleic Acids Res       Date:  2013-10-22       Impact factor: 16.971

6.  DIS3 isoforms vary in their endoribonuclease activity and are differentially expressed within haematological cancers.

Authors:  Sophie R Robinson; Sandra C Viegas; Rute G Matos; Susana Domingues; Marisa Bedir; Helen J S Stewart; Timothy J Chevassut; Antony W Oliver; Cecilia M Arraiano; Sarah F Newbury
Journal:  Biochem J       Date:  2018-06-29       Impact factor: 3.857

7.  Cliques for the identification of gene signatures for colorectal cancer across population.

Authors:  Meeta P Pradhan; Kshithija Nagulapalli; Mathew J Palakal
Journal:  BMC Syst Biol       Date:  2012-12-17

8.  The exosome controls alternative splicing by mediating the gene expression and assembly of the spliceosome complex.

Authors:  Lin Zhang; Yufeng Wan; Guobin Huang; Dongni Wang; Xinyang Yu; Guocun Huang; Jinhu Guo
Journal:  Sci Rep       Date:  2015-08-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.